Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomised Evaluation of COVID-19 Therapy (RECOVERY)

Next Previous
X
Search
Trial Profile

Randomised Evaluation of COVID-19 Therapy (RECOVERY)

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Jul 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aspirin (Primary) ; Aspirin (Primary) ; Baloxavir-marboxil (Primary) ; Baloxavir-marboxil (Primary) ; Casirivimab/imdevimab (Primary) ; Colchicine (Primary) ; Colchicine (Primary) ; Hydrocortisone (Primary) ; Immune globulin (Primary) ; Methylprednisolone (Primary) ; Molnupiravir (Primary) ; Oseltamivir (Primary) ; Oseltamivir (Primary) ; Tocilizumab (Primary) ; Anakinra; Anakinra; Azithromycin; Azithromycin; Azithromycin; Baricitinib; Baricitinib; Convalescent anti-SARS-CoV-2 plasma; Dexamethasone; Dexamethasone; Dexamethasone; Dimethyl fumarate; Empagliflozin; Hydroxychloroquine; Lopinavir/ritonavir; Lopinavir/ritonavir; Methylprednisolone sodium succinate; Nirmatrelvir+ritonavir; Prednisolone; Sotrovimab
  • Indications Community-acquired pneumonia; COVID-19 pneumonia; Influenza A virus infections; Influenza B virus infections; SARS-CoV-2 acute respiratory disease
  • Focus Therapeutic Use
  • Acronyms RECOVERY

    • Most Recent Events

    • 02 Jan 2024 Number of treatment arms changed from 19 to 23.
    • 02 Jan 2024 Planned primary completion date changed from 1 Nov 2023 to 30 Jun 2026.
    • 14 Dec 2023 Planned End Date changed from 1 Nov 2032 to 30 Jun 2036.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top